R&D Tax Incentives


The Guidance Notes below cover a broad range of applied knowledge in respect of research and development tax incentives that has been provided to our clients, and updated to reflect the companies’ feedback and practical experience.

  • GNT 1: Qualifying Expenditure – SME

    Expenditure can only be included in a claim for R&D tax relief if it relates to a project that fulfils the criteria of qualifying research and development under the BIS Guidelines for Research and Development. Once the project has been identified, a company can claim qualifying expenditure if it falls within an exhaustive list of qualifying categories for SMEs. This Guidance Notes sets out and explains each relevant category of qualifying expenditure for R&D purposes. (Password required)

    MORE

  • GNT 2: Qualifying Expenditure – RDEC

    Expenditure can only be included in a claim for R&D tax relief if it relates to a project that fulfils the criteria of qualifying research and development under the BIS Guidelines for Research and Development. Once the project has been identified, a company can claim qualifying expenditure if it falls within an exhaustive list of qualifying categories under RDEC. This Guidance Notes sets out and explains each relevant category of qualifying expenditure for R&D purposes. (Password required)

    MORE

  • GNT 5: Subsidised R&D - for Claimants Under the SME Scheme

    The extent to which expenditure is subsidised or provided in the form of government grants can have a significant impact on the amount of R&D incentives that a company can claim under the SME regime. This note summarises when R&D would be regarded as being subsidised and the impact it has on R&D incentives claims. (Password required)

    MORE

  • GNT 8: R&D Incentives Chart of Accounts

    If you are setting up a new company or are in the process of implementing new accounting systems, it may be worthwhile designing a chart of accounts to allow straight forward identification of qualifying R&D expenditure at the end of the year. This Guidance Note makes recommendations of appropriate cost centres within a chart of accounts. (Password required)

    MORE

  • GNT 18: Going Concern Requirement for SME R&D Incentives

    For a company to be eligible for SME R&D incentives, it must file its accounts as a Going Concern. This guidance note summarises the Going Concern principle, the responsibilities of both Management and Auditors in assessing its applicability and how the process evolves for both audited and unaudited Life Sciences companies. (Password required)

    MORE

  • GNT 19: BIS Guidelines for R&D

    This guidance note summarises the key requirements for BIS Guidelines for Research and Development which determine the extent to which qualifying activities can be claimed for R&D tax incentives. (Password required)

    MORE

  • GNT 22: Qualifying Direct and Indirect Activities for R&D Tax Incentives

    This guidance note serves as a tool to allow companies to determine objectively what activities can be included in the R&D claim. (Password required)

    MORE

  • GNT 27: SME R&D Regime Essentials

    This note provides a high level overview of the SME R&D Tax Incentive Scheme for those unfamiliar with the basics. (Password required)

    MORE

  • GNT 28: Sub-contract R&D and Externally Provided Workers

    In a group of companies it is not uncommon for one company to perform R&D services for another, particularly where R&D hubs are established in other territories. This note summarises some key points and issues that arise when one company provides R&D services to another. (Password required)

    MORE

  • GNT 31: SME R&D Tax Credit and RDEC Comparison

    Delivering 33p/£, the SME R&D Tax Credit is one of the most valuable regimes of its nature across the globe.  Companies qualifying for this incentive may nevertheless need to claim under the less generous Research & Development Expenditure Credit (‘RDEC’) which generates 9p/£. This may arise when the company provides sub-contract R&D services to another, receives a subsidy or exceeds the size criteria by virtue of its own growth or by acquisition. This Guidance Note compares the two regimes. (Password required)

    MORE

  • GNT 36: Enhancing R&D Incentives on Clinical Trials

    This guidance note outlines some of the taxation opportunities for sponsors when engaging with Contract Research Organisations (CROs). With planning, the Sponsor is likely to improve R&D incentives under both the SME R&D scheme and RDEC (for large enterprises). With larger Phase II and III trials the savings can be material. For international trials, the Sponsor may also be incurring VAT and other indirect taxes on pass-through costs that could be recoverable. (Password required)

    MORE

  • GNT 41: RDEC – Essentials

    This note provides a high level overview of the Research and Development Expenditure Credit (RDEC) Scheme for those unfamiliar with the basics. (Password required)

    MORE

More Info

Share this page

Inside N-Site

Subscribe Now

Up-to-date information on tax developments within the UK Life Sciences Industry.

Subscribe

Request a Guidance Note

More

FTI N-Site Information

More